（ASX: LPM）继稀土铀矿之后Moonlight再添重磅金矿资产 计划携黄金与关键矿产项目组合澳交所上市

Group 1: Lithium Plus Minerals and Moonlight Resources - Lithium Plus Minerals (ASX: LPM) announced the acquisition of the high-potential Clermont gold project in Queensland from Diatreme Resources (ASX: DRX) through its 44.7% owned entity, Moonlight Resources [3] - Moonlight Resources now holds approximately 5,200 square kilometers of mining rights across Northern Territory, New South Wales, and Western Australia, including promising rare earth and uranium exploration rights in the MacDonnell Ranges [3] - The acquisition is expected to enhance Moonlight's asset portfolio, focusing on gold and critical mineral exploration, with resource definition anticipated to be completed soon [5] Group 2: Lynas Rare Earths - Lynas Rare Earths Ltd (ASX: LYC) announced a fully underwritten equity financing plan to raise AUD 750 million to expand rare earth production capacity [8] - The financing aims to capitalize on government interventions that have led to a 40% increase in rare earth prices over the past month, with Lynas's market capitalization rising nearly 80% [8] - Lynas's CEO emphasized the importance of securing sufficient resources to leverage market opportunities as the company prepares for growth [8] Group 3: Electro Optic Systems Holdings - Electro Optic Systems Holdings Limited (ASX: EOS) announced its successful bid as a systems integration partner for the Australian Defence Force's LAND 156 project, leading to a 13.88% increase in its stock price [12] - The project is part of a AUD 1.3 billion investment plan over the next decade aimed at developing advanced counter-drone capabilities [12] Group 4: Invictus Energy - Invictus Energy Ltd (ASX: IVZ) established a strategic partnership with Al Mansour Holdings, backed by a member of the Qatari royal family, to support the commercialization of the Cabora Bassa gas project [14] - The partnership includes a plan for AMH to acquire 19.9% of Invictus and provide up to USD 500 million in future financing [14] - Following the announcement, Invictus's stock surged by 145.28% [14] Group 5: McPherson's Limited - McPherson's Limited (ASX: MCP) reported a 3.9% decline in revenue to AUD 139 million and a net loss of AUD 16.6 million for the fiscal year ending June 30 [17] - The company is transitioning to a lighter asset model to drive future growth [17] Group 6: Neuren Pharmaceuticals - Neuren Pharmaceuticals (ASX: NEU) reported a net profit of AUD 15 million for the first half of the 2025 fiscal year, an increase of 87.5% year-on-year, driven by revenue from its core product DAYBUE [21][22] - The company is advancing its second candidate drug, NNZ-2591, with significant progress in clinical development for various rare neurodevelopmental disorders [24] - Neuren's cash and short-term investments reached AUD 300 million, providing a strong financial foundation for future research and market expansion [25] Group 7: Fortescue Metals Group - Fortescue Metals Group (ASX: FMG) reported a 41% decline in net profit to USD 3.4 billion (AUD 5.24 billion) for the fiscal year, with revenue down 15% to USD 15.54 billion [28] - The company is focusing on green hydrogen and decarbonization projects as part of its future strategy [28] Group 8: Sigma Healthcare - Sigma Healthcare Ltd (ASX: SIG) reported a 41% increase in EBITDA to AUD 903.4 million following its reverse acquisition of Chemist Warehouse [32] - The company plans to cut costs by AUD 100 million, exceeding its initial target of AUD 60 million [32]